Literature DB >> 19879327

Phosphorylation-acetylation switch in the regulation of STAT1 signaling.

Oliver H Krämer1, Thorsten Heinzel.   

Abstract

STAT1 signaling regulates the expression of important genes controlling cell growth, differentiation, apoptosis, and immune functions. Biochemical and genetic experiments have identified how this cascade is modulated. Phosphorylation of STAT1 tyrosine and serine moieties is induced rapidly by cytokines and growth factors. Upon nuclear translocation, phosphorylated STAT1 homo- and heterodimers activate gene expression. Inactivation of phosphorylated nuclear STAT1 has to be precisely regulated in order to allow signal transduction within limited time frames. Lysine acetylation has recently been appreciated as a novel mechanism regulating signal transduction events relying on STAT proteins. Here, we review these analyses and the finding that a switch from phosphorylated to acetylated STAT1 regulates acetylation-dependent dephosphorylation of STAT1 via the T cell tyrosine phosphatase. We discuss how these observations can be integrated into our current understanding of STAT-dependent cytokine signaling and its potential relevance for endocrine functions. 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19879327     DOI: 10.1016/j.mce.2009.10.007

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  43 in total

1.  Increased EGFR expression induced by a novel oncogene, CUG2, confers resistance to doxorubicin through Stat1-HDAC4 signaling.

Authors:  Sirichat Kaowinn; Seung Won Jun; Chang Seok Kim; Dong-Myeong Shin; Yoon-Hwae Hwang; Kyujung Kim; Bosung Shin; Chutima Kaewpiboon; Hyeon Hee Jeong; Sang Seok Koh; Oliver H Krämer; Randal N Johnston; Young-Hwa Chung
Journal:  Cell Oncol (Dordr)       Date:  2017-08-03       Impact factor: 6.730

2.  Stat1 stimulates cap-independent mRNA translation to inhibit cell proliferation and promote survival in response to antitumor drugs.

Authors:  Shuo Wang; Christos Patsis; Antonis E Koromilas
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

3.  Inhibitor of κB kinase epsilon (IKK(epsilon)), STAT1, and IFIT2 proteins define novel innate immune effector pathway against West Nile virus infection.

Authors:  Olivia Perwitasari; Hyelim Cho; Michael S Diamond; Michael Gale
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

4.  Chromatin dynamics of gene activation and repression in response to interferon alpha (IFN(alpha)) reveal new roles for phosphorylated and unphosphorylated forms of the transcription factor STAT2.

Authors:  Barbara Testoni; Christine Völlenkle; Francesca Guerrieri; Sabine Gerbal-Chaloin; Giovanni Blandino; Massimo Levrero
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

5.  Structural variants of IFNα preferentially promote antiviral functions.

Authors:  Nancy Vázquez; Hana Schmeisser; Michael A Dolan; Joseph Bekisz; Kathryn C Zoon; Sharon M Wahl
Journal:  Blood       Date:  2011-07-14       Impact factor: 22.113

Review 6.  Toxoplasma Effectors Targeting Host Signaling and Transcription.

Authors:  Mohamed-Ali Hakimi; Philipp Olias; L David Sibley
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

7.  Comprehensive network map of interferon gamma signaling.

Authors:  Mohd Younis Bhat; Hitendra S Solanki; Jayshree Advani; Aafaque Ahmad Khan; T S Keshava Prasad; Harsha Gowda; Saravanan Thiyagarajan; Aditi Chatterjee
Journal:  J Cell Commun Signal       Date:  2018-09-06       Impact factor: 5.782

8.  STAT1 signaling is not regulated by a phosphorylation-acetylation switch.

Authors:  Filipa Antunes; Andreas Marg; Uwe Vinkemeier
Journal:  Mol Cell Biol       Date:  2011-05-16       Impact factor: 4.272

9.  Novel identification of STAT1 as a crucial mediator of ETV6-NTRK3-induced tumorigenesis.

Authors:  Jinah Park; Junil Kim; Bora Park; Kyung-Min Yang; Eun Jin Sun; Cristina E Tognon; Poul H Sorensen; Seong-Jin Kim
Journal:  Oncogene       Date:  2018-02-02       Impact factor: 9.867

10.  Inhibition of HDAC enhances STAT acetylation, blocks NF-κB, and suppresses the renal inflammation and fibrosis in Npr1 haplotype male mice.

Authors:  Prerna Kumar; Venkateswara R Gogulamudi; Ramu Periasamy; Giri Raghavaraju; Umadevi Subramanian; Kailash N Pandey
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.